ArticleBiomolecules & therapeutics2020

Transforming Growth Factor β Receptor Type I Inhibitor, Galunisertib, Has No Beneficial Effects on Aneurysmal Pathological Changes in Marfan Mice.

Jeong-Ho Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.